JOHN MANALOOR to Immunoglobulins, Intravenous
This is a "connection" page, showing publications JOHN MANALOOR has written about Immunoglobulins, Intravenous.
Connection Strength
0.291
-
Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin. JAMA Netw Open. 2020 01 03; 3(1):e1918565.
Score: 0.150
-
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease. Contemp Clin Trials. 2019 04; 79:98-103.
Score: 0.141